Dalius Jankevicius

Dalius Jankevicius has a diverse work experience in various roles and industries. Dalius currently serves as the CFO at Atrandi Biosciences | Droplet Genomics since December 2022. Previously, Dalius was the Accounting Lead at Verse from July 2021 to November 2022. From October 2019 to March 2020, they held the position of CEO at FrontIT. Before that, Dalius worked at CPP Investment Board, where they had multiple roles, including Senior Associate, Portfolio Value Creation from June 2019 to October 2019, Associate, Portfolio Value Creation from February 2018 to May 2019, and Manager, Investment Governance from November 2014 to January 2018. Prior to their time at CPP Investment Board, Dalius worked at Deloitte Luxembourg as a Manager from September 2013 to November 2014, Senior Auditor from February 2013 to August 2013, Audit Supervisor (Assistant Manager) from November 2011 to January 2013, and Experienced Auditor from September 2009 to October 2011. Dalius started their career at Auditeja, UAB as an Auditor's Assistant/Accountant from September 2006 to August 2009 and had an internship at KPMG Baltics, UAB in the Tax department in July 2008.

Dalius Jankevicius completed their Bachelor's degree in Economics from Kaunas University of Technology between 2005 and 2009. In 2007, they also had the opportunity to participate in an exchange program at the National University of Singapore, where they studied Economics and Accounting. Prior to their university education, Dalius obtained their High School Diploma from Kaunas University of Technology Gymnasium from 2001 to 2005.

Additionally, Dalius has acquired further certifications. In August 2012, they obtained the ACCA certification from ACCA, and in October 2011, they became a Certified Auditor through the Lithuanian Chamber of Auditors.